 1981 |
Founding of the forerunner of CMT, Fidelity Medical Services (Israel) Ltd. At that time, Fidelity was engaged in the development, manufacturing and marketing of a product line used by cardiologists in the detection and diagnosis of heartbeat irregularities. |
| 1982 |
Acquisition of the Company by Fidelity Medical Inc., a U.S. company, making the Company a wholly owned subsidiary. The subsidiary’s business was refocused to medical imaging, leading to the launch of the FluoroPlus family of cathlab digital imaging products in 1987. |
| 1993 |
Full purchase of the subsidiary by a group of Israel-based investors. |
| 1994 |
$1M investment in the Company by Israel Industrial Venture Group, L.P. (IIVG), a US-based venture capital fund, in exchange for a 12.6% stake in the Company. |
| 1995 |
Introduction of a new line of products: the SmartSpot family of high performance digital imaging systems for fluoroscopy and angiography applications. This introduction enabled the Company to enter into OEM agreements with major X-ray equipment manufacturers, resulting in a financial turnaround, and profitability in the second half of 1997. |
| 1996 |
CMT Medical Technologies Inc. (CMT Inc.), established as a wholly-owned US subsidiary (registered as a Delaware Corporation) to market and service CMT’s products in North America.
CMT Inc. is located at 20 East Sunrise Highway, Suite 303 Valley Stream, NY 11581, USA. Tel. (516) 825-5500.
|
| February 1999 |
Investment by CMT in Medibell Medical Vision Technologies Ltd., a designer and manufacturer of digital imaging systems for ophthalmology applications. Medibell is now a CMT subsidiary. See www.medibell.com for more information. |
| May 17, 1999 |
Initial Public Offering (IPO) on the Nouveau Marché Paris base public exchange. CMT continues to be traded on the exchange. |
| 2003 |
20% purchase of CMT equity by Shamrock Capital Growth Funds, L.P., an affiliate of Shamrock Holdings. Inc., which is the private investment vehicle of the Roy E. Disney family. The shares were acquired outside the market from Paul Capital Partners (a variety of entities managed by a US private equity firm).
Near year-end, CMT announced the new SmartRAD product line, a platform for Digital Radiography (DR) as a replacement to conventional film radiography. The company entered the DR market by establishing OEM relationships with a number of vendors of general X-ray rooms.
|